Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study

We appreciate the interest of Drs C ălugăru in our recently published COMRADE-C trial1 comparing the clinical efficacy and safety of ranibizumab vs dexamethasone in macular edema secondary to central retinal vein occlusion (CRVO).

Source: American Journal of Ophthalmology - July 7, 2016 Category: Opthalmology Authors: Hans Hoerauf, Nicolas Feltgen, Claudia Weiss, Eva-Maria Paulus, Steffen Schmitz-Valckenberg, Amelie Pielen, Pankaj Puri, H üsnü Berk, Nicole Eter, Peter Wiedemann, Gabriele E. Lang, Matus Rehak, Armin Wolf, Thomas Bertelmann, Lars-Olof Hattenbach, COMRA Tags: Correspondence Source Type: research